Balchem Corporation: updates and filings

BCPCNASDAQBasic materials · Chemicals & Allied Products

Price

$168.73

November 18, 2026Market cap $5.4B

What Ploutos Investor adds for Balchem

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 17 fiscal years, from 2009
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

What comes next, and what happened

Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.

Next results

in 68 daysAround Jan 26, 2027 · for Q4 2026

last Oct 23, 2026next Jan 26, 2027

An estimate from when it has reported before, which has been regular. The company announces the date itself.

Its SEC filings

What it has filed lately, newest first, linked to the document itself.

Feb 20, 2026 latest annualOct 23, 2026 latest quarterly
  • Oct 23, 2026Quarterly reportfor the period to Sep 30, 2026
    Form10-Q
  • Oct 23, 2026Results of operations
    Form8-K
  • Jul 31, 2026Quarterly reportfor the period to Jun 30, 2026
    Form10-Q
  • Jul 31, 2026Results of operations
    Form8-K
  • Jul 27, 2026Material agreement entered, new material financial obligation
    Form8-K
  • Jun 22, 2026Shareholder vote
    Form8-K
  • Jun 18, 2026Employee stock plan reportfor the period to Dec 31, 2025
    Form11-K
  • Apr 30, 2026Quarterly reportfor the period to Mar 31, 2026
    Form10-Q
  • Apr 30, 2026Results of operations
    Form8-K
  • Apr 29, 2026Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • Apr 28, 2026Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • Apr 27, 2026Additional annual meeting material
    FormDEFA14A
  • Apr 27, 2026Annual meeting proxy statement
    FormDEF 14A
  • Mar 26, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Feb 20, 2026Annual reportfor the period to Dec 31, 2025
    Form10-K
  • Feb 20, 2026Results of operations
    Form8-K
  • Feb 19, 2026Officer or director change
    Form8-K
  • Dec 10, 2025Regulation FD disclosure
    Form8-K
  • Dec 8, 2025Filing (amendment)
    Form144/A
  • Oct 21, 2025Quarterly reportfor the period to Sep 30, 2025
    Form10-Q
  • Oct 21, 2025Results of operations
    Form8-K
  • Jul 31, 2025Quarterly reportfor the period to Jun 30, 2025
    Form10-Q
  • Jul 31, 2025Results of operations
    Form8-K
  • Jul 18, 2025Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Jun 24, 2025Employee stock plan reportfor the period to Dec 31, 2024
    Form11-K

From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Aug 11, 1995.

The full analysis

What do Balchem's filings show?

The filings are where every one of Balchem's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

All filings on EDGAR

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.